Peiying Yang is an Associate Professor at Department of Palliative, Rehabilitation and Integrative Medicine at the University of Texas MD Anderson Cancer Center. She received her undergraduate and master degree in Pharmacy from the Beijing University of Traditional Chinese Medicine. Following a year and half of study in Department of Pharmaceutical Science at University of Kentucky, College of Pharmacy, she completed her Doctor degree in Nutritional Science from the University of Maine.
Over the past several years, Dr. Yang has been engaged in translational research of traditional Chinese medicine, natural products (oleander, toad skin, sweet gum, sweet leaf tea), and bioactive lipids (omega-3 and omega-6 metabolism) in cancer treatment and prevention through both preclinical and clinical evaluations. Additionally, more recently her laboratory has engaged in understanding the molecular mechanisms of added sugar in breast tumorigenesis. Several of her studies on natural products and cancer treatment and prevention have been funded by NIH or NCI as R01 or R21 grants. These include studies of the chemopreventive effect of fish oil on lung and colon cancer. She also serves as a key co-investigator on an NCI funded grant studying the role of Traditional Chinese Medicine in cancer treatment and symptom management. She has published more than 100 peer reviewed articles and currently serves a board member of Society of Integrative Oncology (SIO), a member of Executive Committee of SIO, and a member of American Botanical Council as well as an Associate Editor for the journal of Integrative Cancer Therapies.